So, Nancy Mace's Gubernatorial Hopes Might've Been Nuked From Orbit...
Scott Pelley Thinks He Runs CBS News; MS NOW Delivers a Gross of...
To Democrats, Cosplaying the Oppression of Women Is 'Fun'
Doug Burgum Schools CNN on What the Real D.C. Clean Up Scandal Should...
This Is How You Stop Mass Shootings at Churches
Javier Milei's Experiment in Pure Free Markets Just Proved the 'Experts' Wrong Again
Florida Scores Major Win to Keep New Electoral Map in Place
Talarico Campaign Refuses to Deny He Had Inappropriate Relationships With Other Staffers
Slain Student's Family Blasts Chicago's Sanctuary Policies After Killer Found With Weapon...
New York's Government Won't Hand Over Documents About the CDL Holder Who Killed...
Graham Platner Ducks Media Interviews After Explosive Sexting Scandal
Anti-Weaponization Fund Gets Scrapped, But That's Not Enough for Chuck Schumer
Federal Court Blocks Trump Administration Ban on Transgender Service Members
Goodbye Pride Month, Hello Nuclear Family Month
She's Back? Janet Mills Hints at Last-Ditch Shake Up in Maine Senate Race
Tipsheet

Biden-Era Abortion Pill Mailing Rule Temporarily Suspended by Appeals Court

Biden-Era Abortion Pill Mailing Rule Temporarily Suspended by Appeals Court
AP Photo/Manuel Balce Ceneta

A federal appeals court in Louisiana has temporarily blocked a Biden-era federal rule that allowed an abortion drug called mifepristone to be sent via mail.

On May 1, the 5th Circuit Court of Appeals granted a stay that temporarily blocked the mailing of the abortion drug while litigation proceeds. 

Advertisement

The state of Louisiana had sued the Food and Drug Administration, U.S. Department of Health and Human Services, and DHS Secretary Robert F. Kennedy Jr. to stop the rule enacted during the Biden administration. 

The Biden FDA had allowed the abortion drug to be prescribed online and mailed without an in-person doctor visit. 

Louisiana sued over the rule under the Administrative Procedure Act. The state said that the FDA approved the mail-order drug based on flawed or missing data, which caused many illegal abortions in the state. 

Taxpayers picked up the tab to care for women who were harmed by mifepristone, court documents said. 

“By ending the in-person dispensing requirement, FDA opened the door for mifepristone to be remotely prescribed to Louisiana women,” the ruling says. “The record shows that the policy now facilitates nearly 1,000 illegal abortions in Louisiana per month.”

The appeals court said that the FDA’s 2023 law interferes with Louisiana law and gives it standing to challenge the law. 

The lawsuit says that Medicaid paid $92,000 from two women who needed emergency care in 2025 caused by complications from out-of-state mifepristone. 


 2026-05-01-  by  scott.mcclallen 



Advertisement

Editor’s Note: Do you enjoy Townhall’s conservative reporting that takes on the radical Left and woke media? Support our work so that we can continue to bring you the truth.

Join Townhall VIP and use promo code FIGHT to receive 60% off your membership.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement